ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Surveys"

  • Abstract Number: 0158 • ACR Convergence 2020

    Relationships Between Disease Patterns in RA and Rheumatology Treatment

    Kelly O'Neill1, Kathryne Marks2, John Davis3 and Cynthia Crowson4, 1Rheumatoid Patient Foundation, Orlando, FL, 2Rosalind Franklin University of Medicine and Science, North Chicago, IL, 3Mayo Clinic, Rochester, MN, 4Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN

    Background/Purpose: We previously showed rheumatoid arthritis (RA) patients report diversity in disease activity (DA) patterns that may be associated with treatment response. Patients who describe…
  • Abstract Number: 1137 • ACR Convergence 2020

    Access to Digital Health in an Urban Rheumatology Population

    Bruce Youm1 and Aruni Jayatilleke2, 1University of the Pacific, Arthur A. Dugoni School of Dentistry, San Jose, CA, 2Section of Rheumatology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA

    Background/Purpose: Advances in treatment of rheumatologic diseases have increased emphasis on physician and patient use of health information technologies (HIT). While studies indicate that e-health…
  • Abstract Number: 0159 • ACR Convergence 2020

    Patient-Reported Data Show the Impact of Time to Diagnosis in RA

    Kelly O'Neill1, Kathryne Marks2, John Davis3 and Cynthia Crowson4, 1Rheumatoid Patient Foundation, Orlando, FL, 2Rosalind Franklin University of Medicine and Science, North Chicago, IL, 3Mayo Clinic, Rochester, MN, 4Mayo Clinic, Rochester, Minnesota, USA, Rochester, MN

    Background/Purpose: Time from diagnosis to treatment has been well established to correlate with better outcomes in rheumatoid arthritis (RA). Treatment delays are often associated with…
  • Abstract Number: 1230 • ACR Convergence 2020

    Curcumin: Prevalence and Perceived Efficacy in the Treatment of Rheumatoid and Psoriatic Arthritis

    Neha Bhaskar1, Lilian Otalora Rojas2, Tara Jehu1, Shazia Beg1 and Neha Bhanusali1, 1University of Central Florida College of Medicine, orlando, 2University of Central Florida HCA Healthcare GME, Orlando

    Background/Purpose: Ancient Eastern medicine has valued the Curcuma longa (turmeric) plant for its powerful medicinal properties. Curcumin is suggested to possess potent anti-inflammatory, antioxidant, antimicrobial,…
  • Abstract Number: 0166 • ACR Convergence 2020

    Prevalence and Impact of Unacceptable Symptom State Among Patients with Psoriatic Arthritis: Results from the National Psoriasis Foundation’s 2019 Annual Survey

    Alexis Ogdie1, George Gondo2, Joseph Merola3, Stacie Bell4 and Alice Gottlieb5, 1University of Pennsylvania, Philadelphia, PA, 2National Psoriasis Foundation, Portland, OR, 3Brigham and Women's Hospital, Harvard Medical School, Newton, MA, 4National Psoriasis Foundation, Portland, 5Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Despite many efficacious therapies for PsA, many patients do not achieve remission.  Ongoing disease activity leads to many downstream effects including diminished functional ability,…
  • Abstract Number: 1461 • ACR Convergence 2020

    Implementation, Feasibility and Acceptability of Take Charge, an Email Series to Increase Knowledge of Lupus Self-Management Skills

    Karin Tse1, Mary Crimmings2, Mike Donnelly2, Reid Dossinger2, Lauren Metelski2 and Latifa Boyce2, 1Lupus Foundation of America, DC, WA, 2Lupus Foundation of America, WASHINGTON, DC

    Background/Purpose: The Lupus Foundation of America developed and launched an educational email series, Take Charge, to provide people with lupus educational information, tools and resources…
  • Abstract Number: 0436 • ACR Convergence 2020

    The Addressing Lupus Pillars for Health Advancement (ALPHA) Project: Establishing Consensus and Prioritization of Global Community Recommendations to Address Major Challenges in Lupus Diagnosis, Care, Treatment and Research

    Karin Tse1, Sanjyot Sangodkar2, Kathleen Arntsen3, Sang-Cheol Bae4, Lauren Bloch2, Ian Bruce5, Erin Connolly-Strong6, Karen Costenbader7, Thomas Dörner8, Sydney Evans9, Timothy Franson2, Kenneth Getz10, Amy Kao11, Kenneth Kalunian12, Bradley Dickerson13, Susan Manzi14, Eric Morand15, Yaritza Peña10, Sandra Raymond16, Brad Rovin17, Laura Schanberg18, Joan Von Feldt19, Victoria Werth20, Angel Williams21, David Zook2 and Leslie Hanrahan16, 1Lupus Foundation of America, DC, WA, 2Faegre Drinker Consulting, Washington, DC, 3Lupus and Allied Diseases Association, Inc., Verona, NY, 4Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 5Centre for Epidemiology Versus Arthritis, The University of Manchester and NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom, 6Mallinckrodt, Austin, TX, 7Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 8DRFZ and Charité University Hospitals, Berlin, Germany, 9Lupus Patient Representative, Riverdale, MD, 10Tufts Center for the Study of Drug Development, Boston, MA, 11EMD Serono (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, 12University of California San Diego, La Jolla, CA, 13Aurinia Pharmaceuticals, Fort Washington, PA, 14Lupus Center of Excellence, Autoimmunity Institute, Allegheny Health Network, Pittsburgh, PA, 15Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia, 16Lupus Foundation of America, Washington, DC, 17The Ohio State University, Columbus, 18Duke University Medical Center, Durham, NC, 19GlaxoSmithKline, WILMINGTON, DE, 20University of Pennsylvania and the Michael J. Crescenz VA Medical Center, Philadelphia, PA, 21Lupus Patient Representative, Richmond, VA

    Background/Purpose: The Addressing Lupus Pillars for Health Advancement (ALPHA) Project is a global consensus effort to identify, prioritize and address top barriers in lupus impacting…
  • Abstract Number: 1568 • ACR Convergence 2020

    Impact of the SARS-CoV-2 Pandemic on a Cohort of Patients with Rheumatic Complications of Immune Checkpoint Inhibitors: A Registry Survey Study

    Nilasha Ghosh1, Aidan Tirpack2, Caroline Benson3, Gregory Vitone3, Karmela Kim Chan2 and Anne Bass1, 1Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Hospital for Special Surgery, New York

    Background/Purpose: It is not known whether cancer patients being treated with immune checkpoint inhibitors (ICI) and/or immunosuppression are more vulnerable to SARS-CoV-2 or more apt…
  • Abstract Number: 0465 • ACR Convergence 2020

    The COVID-19 Pandemic and Its Effect on Patients with Chronic Rheumatologic Disease Regarding the Value of Vaccination Recommendations

    Rebecca Overbury1, Gregory Stoddard2 and Tracy Frech3, 1University of Utah and Primary Children's Hospital, Salt Lake City, UT, 2University of Utah, Salt Lake City, UT, 3University of Utah and Salt Lake Veterans Affair Medical Center, Salt Lake City, UT

    Background/Purpose: Vaccinations are an important component of care in rheumatology as many patients are immunocompromised by treatment therapies. Patients are sometimes reticent to receive recommended…
  • Abstract Number: 1602 • ACR Convergence 2020

    Assessing the Psychometric Properties of a Measure of Patient Empowerment with Patients with Arthritis

    Erin Knight-Zhang1, Kathleen Carluzzo1, Karen Schifferdecker1, Emily Creek2, Rebecca Butcher1 and Guy Eakin2, 1Dartmouth College, Lebanon, NH, 2Arthritis Foundation, Atlanta, GA

    Background/Purpose: The Health Care Empowerment Questionnaire (HCEQ) was developed for use in a general sample of patients to measure individual empowerment in health care and…
  • Abstract Number: 0476 • ACR Convergence 2020

    Using Consensus Building to Guide Rheumatology Curriculum Development for Internal Medicine Residents

    Sarah Goglin1 and Jennifer Babik2, 1University of California San Francisco, Burlingame, CA, 2University of California San Francisco, San Francisco, CA

    Background/Purpose: In spite of the increasing burden of rheumatic diseases in the United States, many patients have limited access to rheumatologists. As a result, internists…
  • Abstract Number: 1608 • ACR Convergence 2020

    Survey of Minimally-Invasive Ultrasound-Guided Synovial Biopsy Performed at Rheumatology Centres

    Bernard Dyke1, Mark Maybury2, Stefano Alivernini3, Juan Cañete4, Orazio De Lucia5, João Eurico Fonseca6, Nicola Gullick7, Søren Just8, David Kane9, Juhani Koski10, Antonio Manzo11, Laurent Meric de Bellefon12, Ronan Mullan9, Aurelie Najm13, Arthur Pratt14, Felipe Julio Ramirez Garcia15, Charlotte Rawlings16, Fiona Rayner17, Vasco Romão18, Ilfita Sahbudin2, Darren Tabechian19 and Andrew Filer2, 1Institute of Inflammation and Ageing, University of Birmingham, Birmingham, England, United Kingdom, 2Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 3Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 4Arthritis Unit, Rheumatology Dpt, Hospital Clinic, Barcelona, Spain and IDIBAPS, Barcelona, Spain, 5ASST Gaetano Pini-CTO Orthopedic and Traumatology Specialist Center, Milan, Italy, 6Instituto de Medicina Molecular, Faculdade Medicina Universidade de Lisboa and Centro Hospitalar Universitário Lisboa Norte., Lisboa, Portugal, 7University Hospital Coventry & Warwickshire, Knowle, United Kingdom, 8Svendborg Hospital - Odense University Hospital, Odense, Denmark, 9Tallaght University Hospital, Dublin, Ireland, 10Mikkeli Central Hospital, Mikkeli, Finland, 11IRCCS Policlinico San Matteo Foundation/University of Pavia, Pavia, Italy, 12Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert, Belgium, Brussels, Belgium, 13Nantes University Hospital, Nantes, France, 14Newcastle University, Newcastle upon Tyne, United Kingdom, 15Arthritis Unit, Rheumatology Dpt, Hospital Clinic, Barcelona, Spain, Barcelona, Catalonia, Spain, 16Cardiff University School of Medicine, Cardiff, United Kingdom, 17Newcastle University, Newcastle, United Kingdom, 18Instituto de Medicina Molecular, Faculdade Medicina Universidade de Lisboa and Centro Hospitalar Universitário Lisboa Norte., Lisbon, Portugal, 19University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Ultrasound-guided synovial biopsy (USGSBx) is a well-established minimally-invasive alternative to arthroscopy for sampling synovial tissue.  Adverse event rates in published studies are favourable by…
  • Abstract Number: 0535 • ACR Convergence 2020

    Provider Opinion and Support for Shared Decision-making in Gout Treatment: A Quality Improvement National Survey of Veterans Affairs Rheumatologists

    Jasvinder Singh1, John Richards2, Elizabeth Chang3, Toupin-April, Karine Toupin-April4 and Jennifer Barton5, 1University of Alabama at Birmingham, Birmingham, AL, 2Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 3Phoenix VA Medical Center, Phoenix, AZ, Phoenix, AZ, 4VA Portland Oregon, Portland, OR, 5Oregon University, Portland, OR

    Background/Purpose: To assess rheumatologists’ views and practices related to shared decision making (SDM) in gout treatment.Methods: We performed a cross-sectional electronic survey of rheumatologists at…
  • Abstract Number: 1615 • ACR Convergence 2020

    Assessing Preparation for Care Transition Among Adolescents with Rheumatologic Disease: A Quality Assessment with Patient Survey

    Jordan Roberts1, Olha Halyabar2, Carter Petty3 and Mary Beth Son1, 1Boston Children's Hospital, Boston, MA, 2Children's Hospital/Boston Medical Center, Boston, MA, 3Boston Childrens Hospital, Institutional Centers for Clinical and Translational Research, Boston, MA

    Background/Purpose: Despite the risk for poor outcomes and gaps in care in the transition from pediatric to adult care, most pediatric rheumatology centers lack formal…
  • Abstract Number: 0554 • ACR Convergence 2020

    Increased Burden of Painful Arthritis and Rheumatism Following the Chikungunya Epidemic 2006: India Rural Population Survey 2018

    Arvind Chopra1, Ravi Ghorpade2, Anuradha Venugopalan1, Manjit Saluja1 and Kiran Adam1, 1Center for Rheumatic Diseases, Pune, India, 2Center for Rheumatic Diseases, Pune

    Background/Purpose: A spectrum of post Chikungunya (Chik) arthritis , often RA like, were referred to an urban rheumatology centre (Pune India)during the 2006 epidemic (Arthritis…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology